Motor Neuron Disease (MND) — including Amyotrophic Lateral Sclerosis (ALS), Progressive Muscular Atrophy, and related conditions — is a progressive neurodegenerative disease affecting the nerve cells that control voluntary muscle movement. MND has no cure, and it is important to approach any additional treatment option, including stem cell therapy, with realistic expectations. Stem Cell Cure India offers an evaluation to help patients and families understand whether this approach may be relevant to their specific case, alongside — never instead of — ongoing neurology, respiratory, and palliative care.
MND is a serious, progressive condition, and current standard treatments (such as riluzole or edaravone, along with physiotherapy, respiratory support, and multidisciplinary care) aim to slow progression and manage symptoms rather than reverse the disease. Some patients and families look into regenerative approaches such as stem cell therapy as an additional option to discuss with a specialist, while continuing their existing neurology care.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for every patient's individual case.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients before and during their stem cell therapy journey.
Mesenchymal Stem Cells (MSCs) are being studied in research and early clinical trials for potential neuroprotective and anti-inflammatory effects in MND/ALS, with some studies exploring effects on disease progression markers. Results across studies have been mixed, and stem cell therapy is not established as a treatment that halts or reverses MND. It should never be presented as a cure or as a substitute for ongoing neurology care, riluzole/edaravone therapy where prescribed, respiratory monitoring, or palliative support. Any evaluation is offered as an additional, carefully considered option — not a replacement for standard care.
Suitability depends on the specific diagnosis, stage of disease, and current respiratory and functional status. Before travelling, our team reviews:
No. MND/ALS currently has no cure, and stem cell therapy is not established as a treatment that halts or reverses the disease. Any evaluation is offered as an additional option to discuss carefully, alongside — never instead of — the patient's neurology and palliative care team.
Suitability depends on individual respiratory status. Please share recent pulmonary function test results so our team, together with your treating physicians, can advise appropriately.
EMG/NCS reports, brain and spine MRI, ALSFRS-R score if assessed, recent pulmonary function tests, and a diagnosis confirmation letter from the treating neurologist.
Most patients stay between 7 and 10 days, depending on the diagnostic work-up, treatment plan, and any additional support needs.
Yes. Once an evaluation is confirmed, we provide the invitation and supporting documents needed to apply for a Medical Visa.
Cost depends on the specific condition, its severity, and the plan required. Contact us for a personalised quote after sharing your reports and medical history.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews).
Contact Stem Cell Cure India today to share your medical history and get a personalised opinion on suitability.
